Lilly buys migraine-drug maker CoLucid Pharmaceuticals for $960M

Deal will enhance its pain management portfolio for migraine with CoLucid ' s in-development lasmiditan
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news